Outpacing Change: How Life Sciences Companies Use Debt Financing to Thrive
The right funding at the right time is crucial for life sciences companies that want to fuel innovation and scale operations.
Our Life Sciences Group, with some help from our VC partners at RC Capital and KdT Ventures, teamed up with Fierce Biotech for a white paper that covers topics including, adapting to change in today’s economic environment, understanding how to use financing in each growth phase, getting the right support from a banking partner and how debt financing can be the strategic choice for life sciences growth.
Download your free copy of this white paper
Outpacing Change: How Life Sciences Companies Use Debt Financing to Thrive (PDF)
Learn more about Bridge Bank’s Life Sciences Group
Bridge Bank
Bridge Bank, a division of Western Alliance Bank, Member FDIC, delivers relationship banking that puts clients at the center of everything. Founded in 2001 in Silicon Valley, Bridge Bank offers a full spectrum of tailored commercial banking solutions with specialized expertise focused on life sciences and technology and innovation companies at every stage in their life cycle, from startup to IPO and beyond. With offices in major tech hubs across the country, Bridge Bank delivers the reach, resources and market expertise that make a difference for its clients. Bridge Bank also serves the private equity and venture capital communities by providing banking solutions for portfolio companies and funds, plus banking solutions for small to mid-size businesses in the Bay Area. Bridge Bank is part of Western Alliance Bancorporation, which has more than $80 billion in assets. Major accolades include being ranked as a top U.S. bank in 2024 by American Banker and Bank Director.
